Photo of James Holland

James Holland

  • PROFESSOR Medicine, Hematology and Medical Oncology
  • PROFESSOR Oncological Sciences
Print ProfilePrint Profile


  • American Board of Internal Medicine

Clinical Focus


  • MD, Columbia University

  • Residency, Internal Medicine
    Columbia-Presbyterian Medical Center

  • Residency, Internal Medicine
    Columbia-Presbyterian Medical Center

  • Fellowship, Internal Medicine
    Francis Delafield Hospital


    Dr. Holland is the Distinguished Professor of Neoplastic Diseases.


Wang Y, Holland JJ, Bleiweiss IJ, Melana SM, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S, Pogo BG. Detection of mammary tumor virus env gene-like sequences in human breast cancer.. Cancer Res 1995; 55(22): 5173-5179.

Pogo BG, Holland JF. Possibilities of a viral etiology for human breast cancer. A review.. Biol Trace Elem Res Review 1997; 56(1): 131-142.

Melana SM, Holland JF, Pogo BG. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals.. Clin Cancer Res 2001; 7(2): 283-284.

Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG. Identification of a proviral structure in human breast cancer.. Cancer Res 2001; 61(4): 1754-1759.

Levine PH, Pogo B, Klouj A, Coronel S, Woodson K, Melana SM, Mourali N, Holland JF. Increasing evidence for a human breast cancer virus wih geographic differences.. Cancer 2004; 101(4): 721-726.

Holland JF, Pogo B. The Biology Behind. Mouse mammary tumor virus-like infection and human breast cancer.. Cliln Cancer Res 2004 Sept; 10(17): 5647-5649.

Holland JF. Breaking the cure barrier 25 years later.. J Clin Onc 2008; 26(10): 1575.

Pogo B, Holland JF, Levine PH. Human mammary tumor virus in inflammatory breast cancer.. Cancer 2010; 116: 2741-2744.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Holland during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Scientific Advisory Board:

  • Onconova Therapeutics, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.

Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.

Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


17 East 102 Street Floor 5 West Room D5-131
New York, NY 10029

Tel: 212-824-7434
Fax: 212-860-7186
Department of Medicine - Oncology

1470 Madison Avenue
3rd floor
New York, NY 10029

Tel: 212-241-6756
Get Directions
Insurance Plans
  • 1199
  • Aetna
  • Affinity
  • Amerigroup
  • AmidaCare
  • Beech Street
  • Devon Health Services
  • Empire Blue Cross/Blue Shield
  • Fidelis
  • GHI
  • HIP Commercial
  • HIP Medicaid
  • HIP Medicare
  • HealthFirst
  • HealthPlus, Inc.
  • Island Group
  • Magnacare
  • Medicaid of New York
  • Medicare of NY
  • Multiplan/PHCS
  • Neighborhood Health Providers, LLC
  • Oxford Health Plans
  • Pomco
  • United Healthcare
  • VNS Medicare